Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar-Apr;30(2):117-124.
doi: 10.4103/jiaps.jiaps_138_24. Epub 2025 Mar 3.

Correlation of Liver Fibrosis using Noninvasive Transient Elastography with Histological Staging in Infants with Cholestasis - A Prospective Analytical Study

Affiliations

Correlation of Liver Fibrosis using Noninvasive Transient Elastography with Histological Staging in Infants with Cholestasis - A Prospective Analytical Study

Deepti Naik et al. J Indian Assoc Pediatr Surg. 2025 Mar-Apr.

Abstract

Aims: This study primarily aimed to correlate liver fibrosis (LF) assessed by transient elastography (TE) using liver stiffness measurement (LSM score) with liver biopsy fibrosis scoring (METAVIR score) in biliary atresia (BA). Secondary objectives were to assess the diagnostic accuracy of TE in distinguishing BA from other causes of neonatal cholestasis (NC) and the correlation of preoperative LSM score with surgical outcomes 3 months post Kasai portoenterostomy.

Methodology: Infants under 6 months with conjugated hyperbilirubinemia (July 2022-February 2024) were cases and age- and gender-matched healthy infants served as controls. Cases were evaluated using predefined standard diagnostic tests and TE using Fibroscan® Expert 630 (Echosens) device was additionally performed preoperatively and 3 months postoperatively. METAVIR scoring was calculated on liver histopathology.

Results: Fifty-one NC patients (28 boys, 23 girls) were included. A preoperative LSM ≥ 11.4 predicted significant fibrosis (METAVIR score - F3/F4) with 94% sensitivity and 46% specificity (P = 0.053). A preoperative LSM ≥ 13.2 fairly predicted the presence of BA with 74% sensitivity, 71% specificity (P = 0.006), and 72.5% diagnostic accuracy. Median preoperative LSM (interquartile range) for clearance of jaundice (COJ) (14.1 [10.28-18.48]) versus no clearance (15.7 [12.1-35]) showed no statistical difference (P = 0.359).

Discussion and conclusion: TE is an effective noninvasive screening tool to differentiate BA from other causes of NC with a cutoff of >13.2 kPa. The predictive value of TE for postoperative COJ and complications like cholangitis based on the preoperative LF measurements cannot be commented on based on our results.

Keywords: Biliary atresia; METAVIR score; liver biopsy; liver fibrosis; neonatal cholestasis; transient elastography; ultrasound shear wave elastography.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Receiver operating characteristic (ROC) curve analysis showing diagnostic accuracy of preoperative fibroscan in predicting significant fibrosis on biopsy (METAVIR SCORE - F3/F4 is considered significant fibrosis) (n = 51). (b) ROC curve analysis showing diagnostic accuracy of liver stiffness measurement (LSM) (preoperative) in predicting biliary atresia versus other causes of neonatal cholestasis (n = 51). (c) ROC curve analysis showing diagnostic accuracy of LSM (preoperative) in predicting neonatal cholestasis versus controls (n = 102). ROC: Receiver operating characteristic
Figure 2
Figure 2
(a) Association between clearance of jaundice Post 3 months and liver stiffness measurement (LSM) (preoperative), (b) Correlation between preoperative LSM score with 3 months post Kasai portoenterostomy LSM score. LSM: Liver stiffness measurement
Figure 3
Figure 3
(a) Line diagram depicting the change in liver stiffness measurement (LSM) over time in the three groups (complete clearance of jaundice [COJ], reduced COJ and no COJ). (b) Bar diagram depicting the change in LSM over time in three groups (complete COJ, reduced COJ, and no COJ). (c) Line diagram depicting the change in LSM over time in the two groups (postoperative cholangitis vs. no cholangitis). (d) Box- and – Whisker plot depicts the distribution of LSM (preoperative) in the two groups (Pigmented stool vs. Pale stool)

References

    1. Sanchez-Valle A, Kassira N, Varela VC, Radu SC, Paidas C, Kirby RS. Biliary atresia:epidemiology, genetics, clinical update, and public health perspective. Adv Pediatr. 2017;64:285–305. - PubMed
    1. Kim JR, Hwang JY, Yoon HM, Jung AY, Lee JS, Kim JS, et al. Risk estimation for biliary atresia in patients with neonatal cholestasis: Development and validation of a risk score. Radiology. 2018;288:262–9. - PubMed
    1. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374:1704–13. - PubMed
    1. Wang Y, Jia LQ, Hu YX, Xin Y, Yang X, Wang XM. Development and validation of a nomogram incorporating ultrasonic and elastic findings for the preoperative diagnosis of biliary atresia. Acad Radiol. 2021;28(Suppl 1):S55–63. - PubMed
    1. Lee SM, Cheon JE, Choi YH, Kim WS, Cho HH, Kim IO, et al. Ultrasonographic diagnosis of biliary atresia based on a decision-making tree model. Korean J Radiol. 2015;16:1364–72. - PMC - PubMed

LinkOut - more resources